Avenue Therapeutics Inc (ATXI)
OTHER OTC:ATXI
Avenue Therapeutics (ATXI) Ownership Overview
10.32%
Insiders
5.69% Other Institutional Investors
83.99% Public Companies and
Individual Investors
The ownership structure of Avenue Therapeutics (ATXI) stock is a mix of institutional, retail, and individual investors. , 10.32% is owned by Insiders, and 83.99% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 328,524 | Insider | 10.32% | 95,272 | |
| 8,106 | Institution | 0.25% | 3,405 | |
| 618 | Institution | 0.02% | 163 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,106 | Institution | 0.25% | 3,405 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Avenue Therapeutics Inc (ATXI)?
According to the latest TipRanks data, approximately 5.69% of the company's stock is held by institutional investors, 10.32% is held by insiders, and 83.99% is held by retail investors.
What percentage of Avenue Therapeutics Inc (ATXI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.69% of Avenue Therapeutics Inc (ATXI) stock is held by institutional investors.
What percentage of Avenue Therapeutics Inc (ATXI) stock is held by retail investors?
According to the latest TipRanks data, approximately 83.99% of Avenue Therapeutics Inc (ATXI) stock is held by retail investors.
Who owns the most shares of Avenue Therapeutics Inc (ATXI)?
Fortress Biotech, Inc. owns the most shares of Avenue Therapeutics Inc (ATXI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.